Market closedNon-fractional
CVRx/CVRX
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About CVRx
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.
Ticker
CVRX
Sector
Healthcare
Trading on
NASDAQ
Industry
Health Care Equipment and Supplies
Headquarters
Minneapolis, United States
Employees
200
Website
www.cvrx.com
CVRx Metrics
BasicAdvanced
$267M
Market cap
-
P/E ratio
-$2.49
EPS
1.29
Beta
-
Dividend rate
Price and volume
Market cap
$267M
Beta
1.29
Financial strength
Current ratio
12.184
Quick ratio
10.551
Long term debt to equity
45.822
Total debt to equity
46.183
Interest coverage (TTM)
-21.11%
Management effectiveness
Return on assets (TTM)
-29.04%
Return on equity (TTM)
-62.70%
Valuation
Price to revenue (TTM)
6.14
Price to book
3.96
Price to tangible book (TTM)
3.96
Price to free cash flow (TTM)
-6.312
Growth
Revenue change (TTM)
59.59%
Earnings per share change (TTM)
19.70%
3-year revenue growth
80.18%
3-year earnings per share growth
-63.95%
What the Analysts think about CVRx
Analyst Ratings
Majority rating from 6 analysts.
CVRx Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$11M
-5.31%
Net income
-$22M
142.86%
Profit margin
-206.54%
156.48%
CVRx Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.56
-$0.43
-$0.44
-$1.04
-
Expected
-$0.58
-$0.58
-$0.54
-$0.54
-$0.55
Surprise
-4.00%
-25.65%
-19.24%
92.30%
-
CVRx News
AllArticlesVideos
CVRx Announces Appointment of Robert Allen John as Chief Revenue Officer
GlobeNewsWire·2 weeks ago
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of CVRx, Inc. - CVRX
PRNewsWire·4 weeks ago
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of CVRx, Inc. - CVRX
GlobeNewsWire·1 month ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for CVRx stock?
CVRx (CVRX) has a market cap of $267M as of July 06, 2024.
What is the P/E ratio for CVRx stock?
The price to earnings (P/E) ratio for CVRx (CVRX) stock is 0 as of July 06, 2024.
Does CVRx stock pay dividends?
No, CVRx (CVRX) stock does not pay dividends to its shareholders as of July 06, 2024.
When is the next CVRx dividend payment date?
CVRx (CVRX) stock does not pay dividends to its shareholders.
What is the beta indicator for CVRx?
CVRx (CVRX) has a beta rating of 1.29. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.
Buy or sell CVRx stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.